István Puskas

Title: The Innovative Contributions of István Puskas

Introduction

István Puskas is a notable inventor based in Szada, Hungary. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of cyclodextrin derivatives for medical applications. With a total of 2 patents, his work focuses on innovative solutions for treating lysosomal neurodegenerative diseases.

Latest Patents

Puskas's latest patents include groundbreaking inventions that utilize chemically modified cyclodextrins. One of his notable patents is titled "Cyclodextrin derivatives in the treatment or prevention of lysosomal neurodegenerative diseases." This invention relates to the use of single isomer chemically modified cyclodextrins, specifically S-(carboxyalkyl)-thio-cyclodextrin salts, in medications aimed at preventing or treating lysosomal storage diseases. Another significant patent is "Pharmaceutical composition comprising dapagliflozin and cyclodextrin." This invention details pharmaceutical compositions that combine dapagliflozin with cyclodextrin, enhancing the efficacy of the medication.

Career Highlights

Throughout his career, István Puskas has worked with reputable companies such as Ratiopharm GmbH and Cyclolab Cyclodextrin Research and Development Laboratory Ltd. His experience in these organizations has contributed to his expertise in the field of cyclodextrin research and development.

Collaborations

Puskas has collaborated with esteemed colleagues, including Lajos Szente and Tamas Sohajda. These partnerships have fostered innovation and advancement in his research endeavors.

Conclusion

István Puskas is a distinguished inventor whose work in cyclodextrin derivatives has the potential to revolutionize treatments for lysosomal neurodegenerative diseases. His contributions to pharmaceutical sciences highlight the importance of innovation in addressing complex medical challenges.